Consistent with these findings, the quantitative PCR analysis demonstrates that: a) the levels of expression of GPBAR1 gene in cancer cells was similar among patients with or without intestinal metaplasia (Figure 1G), and b) that GPBAR1 mRNA levels did not differentiated among intestinal-type and diffuse-type cases. This evidence concerns the gene GPBAR1 and cancer.